Results 221 to 230 of about 62,608 (262)
Some of the next articles are maybe not open access.
Nonfunctioning Pituitary Tumors and Pituitary Incidentalomas
Endocrinology and Metabolism Clinics of North America, 2008Clinically nonfunctioning adenomas (CNFAs) range from being completely asymptomatic, and therefore detected at autopsy or as incidental findings on head MRI or CT scans performed for other reasons, to causing significant hypothalamic/pituitary dysfunction and visual field compromise because of their large size.
openaire +2 more sources
Hormone Research in Paediatrics, 2007
<i>Background:</i> Pituitary tumors are common and usually grow insidiously over many years. Rarely fatal, treatment still requires multiple cytoreductive surgeries and/or radiation therapy with its attendant side effects. As a disease process of regulatory pathways, pituitary tumors offer numerous potential therapeutic targets, and many ...
openaire +2 more sources
<i>Background:</i> Pituitary tumors are common and usually grow insidiously over many years. Rarely fatal, treatment still requires multiple cytoreductive surgeries and/or radiation therapy with its attendant side effects. As a disease process of regulatory pathways, pituitary tumors offer numerous potential therapeutic targets, and many ...
openaire +2 more sources
Management of Pituitary Tumors
Neurologic Clinics, 1986Pituitary adenomas represent the only true adenomas of the cranial cavity. In 1000 asymptomatic pituitary glands examined at autopsy, there was a 22.4 per cent incidence of undetected microadenomas. Advances in diagnostic endocrinology, in radiologic imaging, and in surgical and medical treatments have brought many more patients to the attention of the
K D, Post, K, Muraszko
openaire +2 more sources
2005
Few human pituitary tumor cell lines have been established. This scarcity may be related to the fact that hormone production rapidly declines within weeks to months after initiation of the culture. In addition, the number of proliferating cells in pituitary adenomas is very low.
Hofland, Leo, Lamberts, S.W.J.
openaire +2 more sources
Few human pituitary tumor cell lines have been established. This scarcity may be related to the fact that hormone production rapidly declines within weeks to months after initiation of the culture. In addition, the number of proliferating cells in pituitary adenomas is very low.
Hofland, Leo, Lamberts, S.W.J.
openaire +2 more sources
THE PATHOLOGY OF PITUITARY TUMORS
Endocrinology and Metabolism Clinics of North America, 1999The pathologist plays an important role in the distinction of pituitary adenomas from other tumors and tumor-like lesions of the sellar region, and in the accurate morphologic characterization of pitutiary adenomas. A clinicopathologic classification of pituitary adenomas is based on cell differentiation correlated with clinical evidence of hormone ...
openaire +2 more sources
Pathology - Research and Practice, 1988
Pituitary malignancies are rare. The definition of pituitary malignancy is still subject to debate. Three types of malignancy with the description of clinical course and complete autopsy were presented; i) true carcinosarcoma, ii) ectopic sphenoid invasive tumor, and iii) post-irradiation sarcoma.
openaire +2 more sources
Pituitary malignancies are rare. The definition of pituitary malignancy is still subject to debate. Three types of malignancy with the description of clinical course and complete autopsy were presented; i) true carcinosarcoma, ii) ectopic sphenoid invasive tumor, and iii) post-irradiation sarcoma.
openaire +2 more sources
Anti-Cancer Drugs, 1992
This article reviews the current general approach to the biochemical diagnosis and the treatment of pituitary tumors with special reference to medical treatment with dopamine agonists and somatostatin analogs. Dopamine agonists are the treatment of choice in patients with prolactin producing tumors.
openaire +2 more sources
This article reviews the current general approach to the biochemical diagnosis and the treatment of pituitary tumors with special reference to medical treatment with dopamine agonists and somatostatin analogs. Dopamine agonists are the treatment of choice in patients with prolactin producing tumors.
openaire +2 more sources